AlzBiomarker
Control vs Alzheimer's Disease: neurogranin (CSF)
The level of the synaptic protein neurogranin in the cerebrospinal fluid consistently was found to be lower in control subjects than in people with Alzheimer's disease. Our meta-analysis of more than 20 comparisons showed a highly significant effect (effect size = 0.622, p <0.0001).
Loading data...